Structured Treatment Interruptions with Tenofovir Monotherapy for Simian Immunodeficiency Virus-Infected Newborn Macaques

Similar Items

• CD8(+)-Cell-Mediated Suppression of Virulent Simian Immunodeficiency Virus during Tenofovir Treatment
  od: Van Rompay, Koen K. A., i dr.
  Izdano: (2004)
• Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells
  od: Forthal, Donald N., i dr.
  Izdano: (2006)
• Compared to Subcutaneous Tenofovir, Oral Tenofovir Disoproxyl Fumarate Administration Preferentially Concentrates the Drug into Gut-Associated Lymphoid Cells in Simian Immunodeficiency Virus-Infected Macaques
  od: Van Rompay, Koen K. A., i dr.
  Izdano: (2012)
• Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
  od: Van Rompay, Koen KA, i dr.
  Izdano: (2007)
• Pharmacokinetics of Tenofovir in Breast Milk of Lactating Rhesus Macaques
  od: Van Rompay, Koen K. A., i dr.
  Izdano: (2005)